Meloxicam Suspension
NDC Package 71740-339-11
Package Information
Meloxicam suspension is meloxicam oral suspension is contraindicated in the following patients:Known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to meloxicam or any components of the drug product [see Warnings and Precautions (5.7, 5.9)]History of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. This formulation utilizes a suspension delivery system. Marketed by Avondale Pharmaceuticals, Llc, this product is identified by NDC 71740-339 and is authorized under FDA application NDA021530.
Identification & Billing
- RxCUI: 597406 - meloxicam 7.5 MG in 5 mL Oral Suspension
- RxCUI: 597406 - meloxicam 1.5 MG/ML Oral Suspension
- RxCUI: 597406 - meloxicam 7.5 MG per 5 ML Oral Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 71740 - Avondale Pharmaceuticals, Llc
- 71740-339 - Meloxicam
- 71740-339-11 - 1 BOTTLE, PLASTIC in 1 CARTON / 100 mL in 1 BOTTLE, PLASTIC
- 71740-339 - Meloxicam
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71740-339-11 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 100 ml in 1 bottle, plastic of Meloxicam, a human prescription drug labeled by Avondale Pharmaceuticals, Llc. This product is billed per "ML" milliliter and contains an estimated amount of 100 billable units per package. This suspension is formulated for oral use and contains meloxicam as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Avondale Pharmaceuticals, Llc on November 01, 2005. The current certification is valid through December 31, 2027.
How is this Avondale Pharmaceuticals, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71740033911. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.